SWKH - SWK Holdings Corp

14.45
-0.090   -0.623%

Share volume: 12,566
Last Updated: 04-29-2025
Banking/Business Credit Institutions: -0.07%

PREVIOUS CLOSE
CHG
CHG%
$14.54
-0.09
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
66%
Profitability 70%
Dept financing 25%
Liquidity 75%
Performance 69%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.03%
1 Month
-16.91%
3 Months
-12.32%
6 Months
-12.95%
1 Year
-16.67%
2 Year
-17.14%
Key data
Stock price
$14.45
P/E Ratio 
14.38
DAY RANGE
$14.18 - $14.50
EPS 
$0.81
52 WEEK RANGE
$14.03 - $20.49
52 WEEK CHANGE
-$17.14
MARKET CAP 
194.019 M
YIELD 
N/A
SHARES OUTSTANDING 
12.473 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-14-2025
BETA 
0.14
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$65,119
AVERAGE 30 VOLUME 
$31,526
Company detail
CEO: Joe D. Staggs
Region: US
Website: swkhold.com
Employees: 40
IPO year: 2006
Issue type: Common Stock
Market: XNAS
Industry: Banking/Business Credit Institutions
Sector: Finance, Insurance, And Real Estate

SWK Holdings Corporation provides customized financing solutions to a range of life science companies. Its product pipeline includes Ovarest, an oral leuprolide tablet to treat endocrine disease. The company was founded in 1996 and is headquartered in Dallas, Texas.

Recent news
loading